Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Paraneoplastic rheumatic syndromes.

H J Mitnick1

  • 1Division of Rheumatology, New York University School of Medicine, 333 East 34th Street, New York, NY 10016, USA.

Current Rheumatology Reports
|December 21, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Idiopathic hypertrophic pachymeningitis.

Neurology·2004
Same author

A prospective, double-blind, randomized, placebo controlled trial of methotrexate in the treatment of giant cell arteritis (GCA).

Clinical and experimental rheumatology·2001
Same author

Behçet-type vasculopathy in a patient without the diagnostic features of Behçet's disease.

Arthritis and rheumatism·1996
Same author

Recovery from pulmonary hypertension in an adolescent with mixed connective tissue disease.

Annals of the rheumatic diseases·1992
Same author

Antemortem diagnosis of giant cell aortitis.

The Journal of rheumatology·1990
Same author

Polyarteritis nodosa presenting with migratory soft tissue swelling.

New York state journal of medicine·1987
Same journal

Type I Interferonopathies: Fifteen Years On, From Concept to Therapeutic Perspectives.

Current rheumatology reports·2026
Same journal

Intensive Care Management of ANCA-associated Vasculitides: a Narrative Review.

Current rheumatology reports·2026
Same journal

The Role of Musculoskeletal Ultrasound in Psoriatic Arthritis: From Preclinical Detection to Treatment Monitoring.

Current rheumatology reports·2026
Same journal

Correction to: Is Gout and Autoinflammatory Disease?

Current rheumatology reports·2026
Same journal

Risks and Management of Glucocorticoid Therapy for Patients with Rheumatic Disease Having Surgery.

Current rheumatology reports·2026
Same journal

Perioperative Management Considerations for Patients with Systemic Lupus Erythematosus.

Current rheumatology reports·2026
See all related articles

Paraneoplastic rheumatic syndromes are complex but recent advances clarify clinical presentations and inflammation

Area of Science:

  • Rheumatology
  • Oncology
  • Immunology

Background:

  • Paraneoplastic rheumatic syndromes present significant clinical and research challenges.
  • Recent progress has improved the understanding of these syndromes' clinical features.

Purpose of the Study:

  • To review advancements in understanding paraneoplastic rheumatic syndromes.
  • To explore the role of inflammation mediators in pathogenesis.
  • To connect insights from paraneoplastic syndromes to common rheumatic diseases.

Main Methods:

  • Literature review of recent clinical and research progress.
  • Analysis of advancements in defining and quantifying inflammation mediators.
  • Synthesis of findings to address pathogenesis and broader rheumatic disease questions.

Related Experiment Videos

Main Results:

  • Clinical syndromes associated with paraneoplastic conditions are better defined.
  • Quantification of inflammatory mediators offers new insights into disease mechanisms.
  • Understanding paraneoplastic syndromes may illuminate common rheumatic diseases.

Conclusions:

  • Progress in defining paraneoplastic rheumatic syndromes aids clinical management and research.
  • Investigating inflammation mediators is key to understanding pathogenesis.
  • Insights gained may have implications for a wider range of rheumatic diseases.